Campbell & Co Investment Adviser’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,036
| Closed | -$2.03M | – | 1132 |
|
|
2025
Q1 | $2.03M | Buy |
13,036
+7,001
| +116% | +$1.09M | 0.16% | 197 |
|
|
2024
Q4 | $831K | Sell |
6,035
-441
| -7% | -$60.7K | 0.06% | 464 |
|
|
2024
Q3 | $967K | Sell |
6,476
-10,784
| -62% | -$1.61M | 0.07% | 455 |
|
|
2024
Q2 | $2.35M | Buy |
+17,260
| New | +$2.35M | 0.2% | 124 |
|
|
2024
Q1 | – | Sell |
-3,997
| Closed | -$503K | – | 1094 |
|
|
2023
Q4 | $503K | Buy |
+3,997
| New | +$503K | 0.05% | 710 |
|
|
2021
Q4 | – | Sell |
-2,900
| Closed | -$462K | – | 615 |
|
|
2021
Q3 | $462K | Buy |
+2,900
| New | +$462K | 0.15% | 240 |
|